Trump confirms Makary out at FDA
President Donald Trump confirmed on Tuesday that Marty Makary would be leaving his post atop the U.S. Food and Drug Administration.
While speaking to reporters on the White House lawn Tuesday, Trump said Makary would be leaving. He said FDA deputy commissioner Kyle Diamantes will take over as the adminsitration seeks a new leader of the federal agency.
“He was having some difficulty,” Trump said. “Marty is a terrific guy, but he’s going to go and lead a good life.”
Trump did not specify what kind of difficulty Makary experienced. Several reports circulated that there was an internal dispute over approval for flavored vapes at the FDA. The Wall Street Journal reported that Trump pressured Makary to approve fruit-flavored vapes, but he was hesitant to do so.
Trump said many people are seeking the job atop the agency.
Makary was expected to testify on Capitol Hill Wednesday to present the FDA’s budget for the upcoming fiscal year. Diamantes is expected to take his place.
Makary was confirmed to lead the FDA in March 2025. Since then, he’s sought to make several changes to the agency’s policies and change organizational structure. Makary sought to limit antidepressants for pregnant women and ban kratom byproducts.
“He’s a friend of mine, he’s a wonderful man and he’s going to be off,” Trump said of Makary.
Latest News Stories
Chicago loses 2,100 restaurant jobs as industry fights mandated wage hikes
State Senator, ‘angel parent’ want to let police to work with ICE
U.S. Supreme Court temporarily allows mail-order abortion pills
U.S. Supreme Court declines to hear Washington COVID-19 speech case
‘Project Freedom’ begins, two ships safely transit Strait of Hormuz
Meeting Summary and Briefs: Lincoln-Way Community High School District 210 for April 16, 2026
Supreme Court declines hearing Chicago gun sales case
Meeting Summary and Briefs: Will County Board for April 16, 2026
Illinois Quick Hits: Google settlement wins praise from Illinois AG
Illinois diversity commission says businesses aren’t cooperating
U.S. House, Senate, governor on Ohio primary ballots Tuesday
Watchdog says healthcare providers may be misrepresenting child gender treatments as routine care